Physician
Kroin, Veronika
Kroin, Veronika was paid $4.74M by Medicaid between Jan 2018 and Dec 2024, across 74 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoKROIN, VERONIKA
WHEELING, IL 60090
WHEELING, IL 60090
33aNPI1740213925assigned 07/09/2006
33bProvider typePediatrics Physician
28Total paid$4.74M
24GClaims151,540
24DCodes billed74
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#11 of 1,805
Median peer was paid$55K
This provider vs. median86×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,636 | $833K | |
| 2019 | 22,365 | $676K | |
| 2020 | 20,557 | $507K | |
| 2021 | 21,905 | $682K | |
| 2022 | 23,828 | $843K | |
| 2023 | 23,043 | $607K | |
| 2024incomplete | 20,206 | $594K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 28,692 | 23,020 | $1.41M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 19% | 2,640 | 2,129 | $919K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.4% | 4,252 | 3,685 | $353K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.9% | 3,696 | 3,313 | $279K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.6% | 3,464 | 2,956 | $266K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.7% | 2,583 | 2,280 | $178K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.4% | 7,195 | 6,599 | $113K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.4% | 3,166 | 2,977 | $112K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 2,822 | 2,627 | $89K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.8% | 350 | 319 | $88K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.4% | 5,637 | 4,920 | $68K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.4% | 3,899 | 3,319 | $64K |
62 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.2% | 3,500 | $56K |
| 80050 | General health panel | 1.1% | 1,079 | $52K |
| 87081 | <1% | 6,009 | $47K | |
| 96127 | <1% | 3,124 | $46K | |
| 90651 | <1% | 1,155 | $43K | |
| 80053 | Comprehensive metabolic panel | <1% | 4,143 | $43K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,222 | $35K |
| 83655 | <1% | 2,803 | $33K | |
| 92551 | <1% | 2,078 | $32K | |
| 90686 | <1% | 2,737 | $31K | |
| 90670 | <1% | 1,692 | $30K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 351 | $29K |
| 80061 | Lipid panel | <1% | 3,493 | $27K |
| 90734 | <1% | 1,091 | $26K | |
| 99173 | <1% | 3,196 | $24K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,150 | $24K |
| 81003 | <1% | 9,243 | $20K | |
| 90698 | <1% | 1,442 | $18K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 701 | $17K |
| 90680 | <1% | 1,273 | $16K | |
| 85018 | <1% | 6,624 | $15K | |
| 36416 | <1% | 3,344 | $14K | |
| D1206 | Topical application of fluoride varnish | <1% | 491 | $13K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 130 | $11K |
| 90677 | <1% | 283 | $11K | |
| 99000 | <1% | 451 | $10K | |
| 90619 | <1% | 585 | $10K | |
| 90744 | <1% | 840 | $9K | |
| 90715 | <1% | 652 | $9K | |
| 90710 | <1% | 370 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 580 | $6K |
| 90633 | <1% | 541 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 715 | $5K |
| 87428 | <1% | 62 | $4K | |
| 90696 | <1% | 270 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 217 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 228 | $3K |
| 90621 | <1% | 86 | $2K | |
| 82465 | <1% | 512 | $2K | |
| 84439 | <1% | 202 | $2K | |
| 90716 | <1% | 94 | $2K | |
| 87088 | <1% | 140 | $2K | |
| 90700 | <1% | 119 | $1K | |
| 90707 | <1% | 51 | $962.63 | |
| 84481 | <1% | 61 | $657.16 | |
| 90685 | <1% | 53 | $511.24 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 209 | $492.04 |
| 87147 | <1% | 97 | $350.20 | |
| 90648 | <1% | 33 | $300.80 | |
| 99051 | <1% | 73 | $284.50 | |
| 86800 | <1% | 23 | $271.40 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 200 | $261.99 |
| 83525 | <1% | 17 | $150.62 | |
| 87070 | <1% | 15 | $93.00 | |
| 86140 | <1% | 14 | $65.80 | |
| 94760 | <1% | 119 | $46.20 | |
| 85652 | <1% | 14 | $36.68 | |
| 99072 | <1% | 184 | $21.25 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 125 | $5.47 |
| 1036F | 0% | 768 | $0.00 | |
| 1003F | 0% | 1,471 | $0.00 | |
| 1040F | 0% | 599 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.